Medical Oncologist
Metastatic breast cancer
Clinical trials in metastatic breast cancer
Clinical trials test new treatments and combinations, and they can be considered at any stage of metastatic breast cancer. They may offer early access and close monitoring, but new treatments are not always better. This page explains phases, finding trials and your rights.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Should you consider a clinical trial for metastatic breast cancer?
- The different phases and kinds of trials
- Possible benefits and drawbacks, in general terms
- The vocabulary, in plain language
- Honest realities of clinical trials
- How to find and join a clinical trial
- Questions to ask the trial team
- Protections for trial participants
- What being in a trial is usually like
- What people assume about clinical trials
- Common questions about clinical trials
The short answer
Should you consider a clinical trial for metastatic breast cancer?
A clinical trial is a carefully designed research study that tests whether a new treatment, a new combination, or a new way of using existing treatments is safe and works better than the current standard. Almost every treatment used today for metastatic breast cancer, including hormone therapy with targeted tablets, HER2-directed medicines, antibody-drug conjugates and immunotherapy, became available because people took part in trials. For people with metastatic breast cancer, trials can offer access to promising treatments before they are widely available, close monitoring by a specialist team, and the chance to help future patients. Trials are considered at every stage, not only when other options are exhausted, and some are designed specifically for the first treatment after a metastatic diagnosis. Taking part is always voluntary. You receive detailed written information, have time to ask questions and discuss it with family, and can withdraw at any time without affecting your usual care. Trials also have downsides: the new treatment may not work better, may cause unexpected side effects, and may require extra visits, scans and blood tests. In many trials, participants are randomly assigned to the new treatment or the current standard.
Eligibility is specific
Each trial has rules about cancer type, previous treatments, test results and general health, so not everyone qualifies for every trial.
Ask early
Some trials require that certain treatments have not yet been given, so asking at the start of each new line keeps options open.
Ethics and safety
Trials are reviewed by ethics committees and regulators, and participants' safety is monitored throughout.
This page gives general information only. Your oncologist can tell you whether a trial may suit you.Types of trials
The different phases and kinds of trials
Each phase answers a different question.
Phase one
Tests safety and the right dose of a new treatment in a small group.
Phase two
Looks at whether the treatment works for a particular cancer type, and gathers more safety data.
Phase three
Compares the new treatment with the current standard in a larger group.
Results often lead to approval.Other studies
Not all research tests new medicines.
Examples include
- Supportive care and symptom trials
- Quality-of-life studies
- Tissue and blood sample research
Weighing it up
Possible benefits and drawbacks, in general terms
Consideration
What it may mean for you
Access to new treatment
Possible benefit before wider availability, though it may not prove better
Close monitoring
More frequent checks, which some find reassuring
Extra visits and tests
More time, travel and sometimes additional biopsies
Unknown side effects
New treatments may cause effects not yet fully known
Treatment costs
Trial medicines are often provided free; check what else is covered
Not sure whether this applies to you?
Ask an oncologistWords you will hear
The vocabulary, in plain language
- Informed consent
- Agreeing to join after understanding the purpose, risks and benefits.
- Randomisation
- Assigning people to treatment groups by chance, for a fair comparison.
- Placebo
- An inactive substance; rarely used alone in cancer trials.
- Eligibility criteria
- The rules for who can join a trial.
- Ethics committee
- An independent group that reviews trials to protect participants.
- Trial registry
- A public database listing clinical trials.
Being straight with you
Honest realities of clinical trials
Trials can be a valuable option, but it is important to go in with realistic expectations.
New does not always mean better
Many treatments tested in trials turn out to be no better than the standard, or have more side effects.
You may not receive the new treatment
In randomised trials, you may be assigned to the standard treatment, which is still effective care.
Availability is limited
Trials are run at selected centres and may not be open near you, or may close to new patients quickly.
Placebo alone is rare
In cancer trials, people are not usually given a placebo instead of active treatment when effective treatment exists.
What this page cannot tell you
It cannot find a trial for you. Ask your oncologist about trials suited to your situation.
Talk to our team
Have a question about your situation?
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Finding a trial
How to find and join a clinical trial
Finding a suitable trial usually starts with your oncologist, who knows your medical details and nearby research centres.
Ask your oncologist
Ask directly whether any trials are open for your cancer type and treatment stage, at your centre or elsewhere.
Search trial registries
India's national clinical trials registry and international registries list trials by condition and location. Your team can help interpret the listings.
Gather your records
Pathology reports, receptor and genetic results, treatment history and recent scans help trial teams check eligibility quickly.
Screening
If you are interested, the trial team will explain the study, give written information and arrange tests to confirm you qualify.
Take your time
You can take the information home, discuss it with family and ask more questions before signing consent.
Before you join
Questions to ask the trial team
Clear answers help you decide with confidence.
About the treatment
What is being tested, and what is known about it so far? What treatment would I receive if I did not join?
About the practicalities
How many extra visits, scans or biopsies are needed? Will travel or accommodation costs be covered? What costs will I or my insurance pay?
About safety
What side effects are expected, and who do I contact at night or at weekends?
About leaving
What happens if I want to stop, or if the treatment does not work?
Your rights
Protections for trial participants
Clinical trials in India follow national rules designed to protect participants.
Voluntary participation
You choose whether to join, and you can leave at any time without losing access to standard care.
Informed consent
Consent information should be explained in a language you understand, and you should receive a copy.
Confidentiality
Your personal information is protected, and results are published without naming you.
Care for trial-related harm
Rules require medical care for injuries related to the trial. Ask the team how this works.
Taking part
What being in a trial is usually like
Knowing what day-to-day participation involves helps you decide whether a trial fits your life and your family's routines.
Screening visits
Before starting, you may have blood tests, scans, a heart check and sometimes a new biopsy to confirm you meet the trial rules. Occasionally, these tests show you are not eligible, which can be disappointing.
Treatment visits
Trial treatment follows a strict schedule. Visits may be more frequent than usual, particularly in the first cycles, and some include extra blood samples at set times.
Recording symptoms
You may be asked to keep a diary or fill in questionnaires about side effects, pain, mood and daily activities. This information helps researchers understand how the treatment affects quality of life.
Staying in touch
A research nurse is usually your main contact. Report any new symptom, hospital visit or new medicine, including herbal products, as these can affect safety and results.
Keeping your own records
Keep copies of consent forms, visit schedules and contact numbers in one folder.
After the trial treatment ends
Follow-up contact may continue for months or years so researchers can learn how people do over the long term.
Commonly believed
What people assume about clinical trials
Trials are only for people with no other options.
Trials are available at many stages, including first-line treatment.
Joining a trial means being a guinea pig.
Trials are closely regulated and monitored for safety.
I might get a placebo instead of treatment.
Cancer trials rarely withhold effective treatment.
Once in, I cannot leave.
You can withdraw at any time.
Questions we are asked
Common questions about clinical trials
Do trials cost money?
Trial medicines and some tests are often provided free, but other costs vary. Ask the trial team.
Will my own oncologist still be involved?
Often yes, working with the trial team.
Can I join a trial at another hospital?
Yes, if eligible. Your oncologist can share records.
What if the trial treatment does not work?
You stop and move to other treatment options.
Are trial results shared?
Results are published, and some teams send summaries to participants.
Do I need extra biopsies?
Some trials require them. This is explained before consent.
Can family members help decide?
Yes. Take the information home and discuss it together.
Who can I ask about trials?
Your oncologist or a research nurse.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Warangal
Vizag
Talk to our team
Speak to a breast cancer specialist
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Sources
- National Cancer Institute — Clinical trials information for patients
- Clinical Trials Registry - India — Clinical Trials Registry of India
- European Society for Medical Oncology — Metastatic breast cancer clinical practice guideline
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.